Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases
Saved in:
Main Authors: | Jinmiao Lu (Author), Xiaohua Ying (Author), Zhiping Li (Author) |
---|---|
Format: | Book |
Published: |
Kerman University of Medical Sciences,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
by: jinmiao Lu, et al.
Published: (2023) -
Pricing of orphan drugs in oncology and rare diseases
by: Mark Nuijten, et al.
Published: (2020) -
Price increase negotiations to address drug shortages in South Korea's national health insurance
by: Seung Rae Yu, et al.
Published: (2023) -
Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence
by: Jinmiao Lu, et al.
Published: (2023) -
The impact of early phase price agreements on prices of orphan drugs
by: Mark Nuijten, et al.
Published: (2021)